Official website of the International Senology Oncology Scientific Community
Editor-in-chief: Dr. Gian Paolo Andreoletti - Oncologist, Science Journalist
Hematological Malignancies
LINKS
M.D. Anderson Cancer Center: Leukemia
M.D. Anderson Cancer Center: Non-Hodgkin’s Lymphoma
M.D. Anderson Cancer Center: Hodgkin’s Lymphoma
Memorial Sloan-Kettering Cancer Center: Leukemias
Memorial Sloan-Kettering Cancer Center: Lymphomas
Memorial Sloan-Kettering Cancer Center: Multiple myeloma
National Cancer Institute: Leukemia
National Cancer Institute: Non-Hodgkin’s Lymphoma
The New England Journal of Medicine, Collections – Leukemia/Lymphoma
LITERATURE
SELECTION
CLINICAL
GUIDELINES
"Rituximab
for the treatment of relapsed chronic lymphocytic leukaemia"
- NICE
- National
Institute For Clinical Excellence, London, UK - www.nice.org.uk
"Rituximab for first line chronic lymphocytic leukaemia" - NICE - National Institute For Clinical Excellence, London, UK - www.nice.org.uk
Follicular
lymphoma - rituximab: Guidance - NICE -
National Institute For Clinical Excellence, London, UK
PRESS RELEASES
"JAK
Inhibitor Provides Rapid, Durable Relief for Myelofibrosis Patients"
- The
University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA -
www.mdanderson.org
"Second-line CML Drugs Evoke Faster, Better Front-line Remissions" - The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA - www.mdanderson.org
"Study details first successful use of expanded umbilical-cord blood units to treat leukemia" - Fred Hutchinson Cancer Research Center, Seattle, WA, USA - www.fhcrc.org
"Multiple myeloma patients experience high response rate with new three-drug combination" - Dana-Farber Cancer Institute, Boston, MA, USA - www.dana-farber.org
"Cholesterol-lowering drugs also may protect stem cell transplant patients from a potentially deadly complication" - Dana-Farber Cancer Institute, Boston, MA, USA - www.dana-farber.org
"First report of using radiolabeled antibodies and stem cell transplantation to successfully treat advanced leukemia" - Fred Hutchinson Cancer Research Center, Seattle, WA, USA - www.fhcrc.org
"Genetic Abnormality May Increase Risk of Blood Disorders" - Memorial Sloan-Kettering Cancer Center, New York, USA - www.mskcc.org
"Lenalidomide Safe as Single Therapy for Elderly CLL Patients - Drug shows activity against chronic lymphocytic leukemia in clinical trial" - The University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA - www.mdanderson.org
"Data confirm dasatinib's effectiveness in resistant chronic myelogenous leukemia" - Dana-Farber Cancer Institute, Boston, MA, USA - www.dana-farber.org
"Vaccine Improves Event-Free Survival for Leukemia Patients" - University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA - www.mdanderson.org
"Drug Combination Effective Against Multiple Myeloma, Researchers Show - New England Journal study shows lenalidomide-dexamethasone slows disease" - University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA - www.mdanderson.org
"Study Finds Heart Failure Is Rare Among Leukemia Patients on Imatinib" - University of Texas, M. D. Anderson Cancer Center, Houston, TX, USA
"Promising treatment target found in Hodgkin lymphoma" - Dana-Farber Cancer Institute, Boston, MA, USA
"Risk of Lymphoma Increases with Hepatitis C Virus Infection" - National Institutes of Health (NIH), U. S. Department of Health and Human Services
"New multiple myeloma drug proves more potent than thalidomide and less toxic" - Dana - Farber Cancer Institute, Boston, MA, USA
"Drug
combination proves effective against myeloma in Phase I trial" -
Dana-Farber Cancer Institute, Boston, MA, USA
NEWS
Treatment for Hodgkin lymphoma and late cardiotoxicity
Treatment for Hodgkin lymphoma and late cardiotoxicity - Blood
Autoimmune diseases and Hodgkin
Lymphoma
Autoimmune diseases and Hodgkin Lymphoma - Journal of the National Cancer Institute
Non Hodgkin's lymphoma and
second malignancy
Non Hodgkin's lymphoma and second malignancy - Journal of Clinical Oncology
Autoimmmune disease and
non-Hodgkin's Lymphoma
Autoimmmune
disease and non-Hodgkin's Lymphoma - Journal of Rheumatology
EDITORIALS
Corticosteroid
treatment in advanced metastatic cancer - Staffan Lundstrom
Underlying
cancers in patients with unprovoked venous-thromboembolism - Marc Carrier, Marc Rodger
Possible
risk of cancer transmission from blood donors to recipients through blood
transfusion -
Olof Nyren
Chemotherapy-related anemia and early versus late epoetin alfa - David J. Straus
Single Agent Arsenic trioxide in the treatment of newly diagnosed acute promyelocytic leukemia - Vikram Mathews
Survivors of childhood cancer and use of health care services - Amanda Shaw
Behavioral and educational functioning in survivors of childhood acute lymphoblastic leukemia - Annemieke Buizer
Oral combination of melphalan, prednisone and thalidomide in elderly patients with multiple myeloma - Sara Bringhen, Antonio Palumbo
An antileukaemia vaccine can overcome tolerance and generate immune responses in leukaemia patients - Raphael F. Rousseau
Plasma EBV-DNA as a biomarker in patients with EBV-positive Hodgkin Lymphoma - Maher Gandhi
Mediastinal irradiation may affect diastolic function - Paul Heidenreich
Lymphoma development risk in various autoimmune disorders - Elias Zintzaras
Pediatric cancer patients and end-of-life care preferences - Michele Cavomela S. Hinds
Thalidomide in combination with dexamethasone in patients with multiple myeloma - Michele Cavo
Non-Hodgkin's
Lymphoma, tobacco smoking and Hepatitis C virus infection -
Renato Talamini
